Multiple myeloma in the elderly patients:From frailty assessment to progress in Immunotherapy

被引：1
作者：
Facon, T. [1 ]
Manier, S. [1 ]
机构：
[1] CHU Lille, Hop Claude Huriez, Serv dhematol, 2 Ave Oscar Lambret, F-59037 Lille, France
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2022年 / 206卷 / 08期
关键词：
Multiple myeloma; Drug Therapy; Therapy; Immunotherapy; Oncogeriatry; Frail elderly patient; STEM-CELL TRANSPLANTATION; OPEN-LABEL; GERIATRIC ASSESSMENT; DEXAMETHASONE; BORTEZOMIB; MELPHALAN; LENALIDOMIDE; PREDNISONE; PHASE-3; DARATUMUMAB;
D O I：
10.1016/j.banm.2022.07.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multiple myeloma is primarily a disease of the elderly patients. Geriatric aspects have been poorly investigated until recently. Frailty assessment is now more frequent and will be useful in the context of significant and sustained therapeutic progress. The recent emergence of immunotherapy with CD38 monoclonal antibodies and upcoming immuno-oncology drugs such as bispecific antibodies will lead to additional progress. The applicability of these complex molecules to elderly and frail patients is a key clinical question.(c) 2022 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：966 / 972
页数：7
相关论文
共 50 条
  • [41] Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years
    Belotti, Angelo
    Ribolla, Rossella
    Cancelli, Valeria
    Crippa, Claudia
    Bianchetti, Nicola
    Ferrari, Samantha
    Bottelli, Chiara
    Cattaneo, Chiara
    Tucci, Alessandra
    De La Fuente Barrigon, Carmen
    Rossi, Giuseppe
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 759 - 765
  • [42] Why Immunotherapy Fails in Multiple Myeloma
    Rodriguez-Lobato, Luis Gerardo
    Oliver-Caldes, Aina
    Moreno, David F.
    de Larrea, Carlos Fernandez
    Blade, Joan
    HEMATO, 2021, 2 (01): : 1 - 42
  • [43] Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
    Bila, Jelena
    Jelicic, Jelena
    Djurasinovic, Vladislava
    Vukovic, Vojin
    Sretenovic, Aleksandra
    Andjelic, Bosko
    Antic, Darko
    Todorovic, Milena
    Mihaljevic, Biljana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07) : 416 - 419
  • [44] A comparison of three different approaches to defining frailty in older patients with multiple myeloma
    Isaacs, Ariel
    Fiala, Mark
    Tuchman, Sascha
    Wildes, Tanya M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (02) : 311 - 315
  • [45] Bispecific antibodies in multiple myeloma treatment: A journey in progress
    Cho, Shih-Feng
    Yeh, Tsung-Jang
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients
    Gozzetti, Alessandro
    Bacchiarri, Francesca
    Sammartano, Vincenzo
    Defina, Marzia
    Sicuranza, Anna
    Mecacci, Bianca
    Zappone, Elisabetta
    Cencini, Emanuele
    Fabbri, Alberto
    Raspadori, Donatella
    Bocchia, Monica
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] Immunotherapy for Multiple Myeloma
    Tamura, Hideto
    Ishibashi, Mariko
    Sunakawa, Mika
    Inokuchi, Koiti
    CANCERS, 2019, 11 (12)
  • [48] Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
    Roussel, Murielle
    Hebraud, Benjamin
    Hulin, Cyrille
    Perrot, Aurore
    Caillot, Denis
    Stoppa, Anne-Marie
    Macro, Margaret
    Escoffre, Martine
    Arnulf, Bertrand
    Belhadj, Karim
    Karlin, Lionel
    Garderet, Laurent
    Facon, Thierry
    Guo, Shien
    Weng, Josh
    Dhanasiri, Sujith
    Leleu, Xavier
    Moreau, Philippe
    Attal, Michel
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1323 - 1333
  • [49] Therapy concepts for elderly patients with multiple myeloma
    Ludwig, H.
    Zojer, N.
    ONKOLOGE, 2014, 20 (03): : 235 - 241
  • [50] Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti-CD38 Antibodies: The EMMY Cohort From 2017 to 2020
    Vincent, Laure
    Decaux, Olivier
    Perrot, Aurore
    Royer, Bruno
    Chalopin, Thomas
    Bobin, Arthur
    Macro, Margaret
    Caillot, Denis
    Karlin, Lionel
    Jacquet, Caroline
    Sonntag, Cecile
    Mohty, Mohamad
    Frenzel, Laurent
    Jaccard, Arnaud
    Manier, Salomon
    Sanhes, Laurence
    Chaoui, Driss
    Moreau, Philippe
    Garlantezec, Ronan
    Texier, Nathalie
    Louni, Chanaz
    Maarouf, Zakaria
    Loiseau, Herve Avet
    Hulin, Cyrille
    Merzoug, Karim Belhadj
    CANCER MEDICINE, 2025, 14 (06):
12345